logo

2.08

2.08 (-1.36%)

As of Jun 14, 2022

Renovorx, Inc. [RNXT]

Source: 

Company Overview

RenovoRxis a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. Our mission is tolead a revolution in oncology therapy by delivering its innovative and targeted intra-arterial (IA) delivery of chemotherapydirectly to solid tumors.

CountryUnited States
Headquarterssan josecalifornia
Phone Number408-800-2649
Industry
CEOShaun R. Bagai
Websitewww.renovorx.com